Form 4: Galera Therapeutics Director Reports Stock Transaction
Insider Transaction (Form 4)
Kevin G Lokay, a Director of Galera Therapeutics, Inc., reported a transaction in 240 shares of common stock on August 3, 2026.
Summary
- Disposition to the issuer: disposed of 240 Stock Option (Right to Buy) on August 3, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kevin G Lokay — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Disposition to the issuer | Stock Option (Right to Buy) | 240 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Disposition to the issuer (240 shares) |
Keywords
insider transaction, Form 4, GRTX, Galera Therapeutics, Inc., neutral, Kevin G Lokay
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.